Neurology Advisor Over 4.4 years of follow-up, the cumulative incidence of MCI was 27% (95% CI, 17%–40%) among patients with long COVID, 5% (95% CI, 2%–10%) among recovered COVID-positive patients, and 1% (95% CI, 0.2%–4%) among COVID-negative control individuals. Long COVID was associated with a higher hazard of MCI compared with individuals without long COVID (hazard ratio [HR], 3.93; 95% CI, 1.86–8.31; P <.001). The hazard of Alzheimer disease (AD)–related MCI was also higher among patients with long COVID (HR, 3.20; 95% CI, 1.14–9.0; P =.027).
Overall, 14% of participants (n=37) were diagnosed with MCI, and 0.4% of participants with long COVID (n=1) were diagnosed with AD dementia. Among those with long COVID, the most common MCI subtype was AD–related MCI.
Fair Use Notice
UNMC Global Center for Health Security staff curate publicly available news and information for educational and informational purposes. Brief excerpts of published articles may be displayed under principles of Fair Use, with credit and links provided to the source publications. All copyrights remain the property of their respective owners.